EUVIMEDEUVIMED entdecken
Crossref

Outcomes in Seronegative Rheumatoid Arthritis and Undifferentiated Arthritis

Andrew Price iD, David Mecham iD, Zachary Kerosky iD, Joshua Hunt iD, Anthony Greco iD, Michael Loncharich iD

Military Medicine · 02.11.2026

DOI: 10.1093/milmed/usag499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, online erschienen am 02.11.2026. Verfasst von Andrew Price und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Walter Reed National Military Medical Center, Bethesda, MD 20814, United States. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Seronegative rheumatoid arthritis (SNRA) and undifferentiated arthritis (UA) are heterogeneous conditions that are often reclassified to more specific diagnoses. We report a retrospective chart review from the United States military health system (MHS) that examines clinical characteristics, reclassification rates, and potential predictors of reclassification in SNRA and UA. Materials and Methods The study included MHS beneficiaries diagnosed with SNRA or UA. Inclusion criteria consisted of a negative rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP) antibody at presentation, synovitis on a rheumatologist’s exam, and treatment with a disease-modifying anti-rheumatic drug (DMARD). We then recorded clinical characteristics including distributions of joint involvement, erosions or extra-articular disease, and the number of clinic visits. We used binomial logistic regression to evaluate for any predictors of future diagnostic reclassification.

Results

One hundred thirty-three patients were included, with an index diagnosis of SNRA in 20 (15%) patients, and UA in 113 (85%) patients. Eighty-five (63.9%) patients were later reclassified to other diagnoses, including SNRA (52.1%), seropositive rheumatoid arthritis (9.4%), psoriatic arthritis (14.6%), spondyloarthritis (14.6%), and other (9.4%). The regression model was statistically significant (X2(7) = 15.747, P = .028) and explained 15% of the variance in diagnostic reclassification. Although most variables failed to reach significance, more clinic visits predicted greater odds of diagnostic reclassification (OR 1.07, CI 1.03-1.12).

Conclusions

Our data indicate a potential association with the frequency of follow-up with the likelihood of future diagnostic reclassification in SNRA and UA, suggesting that diagnostic accuracy may be higher in patients with more frequent follow-up visits.

Autor:innen und Institutionen

  • Department of Rheumatology, Walter Reed National Military Medical Center, Bethesda, MD 20814, United States.
  • Department of Internal Medicine, Walter Reed National Military Medical Center, Bethesda, MD 20814, United States.

ORCID-Profile: Andrew Price, David Mecham, Zachary Kerosky, Joshua Hunt, Anthony Greco, Michael Loncharich

Zitieren

APA

Price, A., Mecham, D., Kerosky, Z., Hunt, J., Greco, A., & Loncharich, M. (2026). Outcomes in Seronegative Rheumatoid Arthritis and Undifferentiated Arthritis. Military Medicine. https://doi.org/10.1093/milmed/usag499

Vancouver

Price A, Mecham D, Kerosky Z, Hunt J, Greco A, Loncharich M. Outcomes in Seronegative Rheumatoid Arthritis and Undifferentiated Arthritis. Military Medicine. 2026. doi:10.1093/milmed/usag499

BibTeX
@article{Price2026,
  author = {Price, Andrew and Mecham, David and Kerosky, Zachary and Hunt, Joshua and Greco, Anthony and Loncharich, Michael},
  title = {Outcomes in Seronegative Rheumatoid Arthritis and Undifferentiated Arthritis},
  journal = {Military Medicine},
  year = {2026},
  doi = {10.1093/milmed/usag499}
}
Kostenlos starten →